IRIS
VITALE, SILVIA RITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 822
EU - Europa 565
AS - Asia 366
SA - Sud America 124
AF - Africa 94
OC - Oceania 1
Totale 1.972
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 811
IT - Italia 351
SG - Singapore 187
BR - Brasile 117
IE - Irlanda 81
CN - Cina 79
CI - Costa d'Avorio 60
IN - India 44
DE - Germania 31
SN - Senegal 25
FI - Finlandia 21
GB - Regno Unito 16
RU - Federazione Russa 14
TR - Turchia 10
KR - Corea 9
CZ - Repubblica Ceca 8
CA - Canada 7
SE - Svezia 7
UZ - Uzbekistan 7
BE - Belgio 6
VN - Vietnam 6
IQ - Iraq 5
PL - Polonia 5
BD - Bangladesh 4
CH - Svizzera 4
ES - Italia 4
NG - Nigeria 4
NO - Norvegia 4
AR - Argentina 3
HK - Hong Kong 3
MA - Marocco 3
MX - Messico 3
UA - Ucraina 3
EC - Ecuador 2
FR - Francia 2
GR - Grecia 2
IL - Israele 2
JP - Giappone 2
NL - Olanda 2
OM - Oman 2
AU - Australia 1
CO - Colombia 1
EG - Egitto 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.972
Salva come PNG Salva come JPEG
Città #
Santa Clara 198
Chandler 150
Singapore 123
Chicago 98
Catania 82
Dublin 81
Abidjan 60
Kochi 35
Ashburn 31
Boardman 29
Dakar 25
Civitanova Marche 23
Palermo 22
Cambridge 20
Lawrence 20
Andover 16
Hefei 15
Turku 15
Bari 13
Milan 12
Munich 12
The Dalles 10
Wilmington 10
Des Moines 9
Grafing 9
Los Angeles 9
Rome 9
Santa Venerina 9
São Paulo 9
Brno 8
Columbus 8
Seoul 8
Beijing 7
Falls Church 7
New York 7
Seattle 7
Aci Catena 6
Belo Horizonte 6
Brussels 6
Messina 6
Nanjing 6
Florence 5
Hanover 5
Pune 5
Saint Petersburg 5
San Giovanni la Punta 5
Abuja 4
Cesa 4
Comiso 4
Cosenza 4
Curitiba 4
Dong Ket 4
Fantina 4
Giardini-Naxos 4
Grammichele 4
Istanbul 4
Mascalucia 4
Modica 4
Tashkent 4
Bedford 3
Bremen 3
Council Bluffs 3
Edinburgh 3
Helsinki 3
Jinan 3
Marília 3
Nicolosi 3
Oslo 3
Rio de Janeiro 3
Rometta 3
San Francisco 3
Warsaw 3
Aci Sant'Antonio 2
Alessandria 2
Basra 2
Belém 2
Boston 2
Boydton 2
Cabo Frio 2
Canoinhas 2
Casablanca 2
Cáceres 2
Fairfield 2
Frankfurt am Main 2
Hanoi 2
Houston 2
Jiaxing 2
Lappeenranta 2
London 2
Madrid 2
Manchester 2
Mandello del Lario 2
Mexico City 2
Montreal 2
Moscow 2
Newham 2
Ostermundigen 2
Palagonia 2
Paternò 2
Redmond 2
Totale 1.408
Salva come PNG Salva come JPEG
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 155
Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily 109
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 95
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 89
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 88
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 87
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? 86
An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA 85
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 84
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 84
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 80
Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience 80
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 79
The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer 79
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 77
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 76
Opportunities and challenges of liquid biopsy in thyroid cancer 69
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far 68
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 68
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 63
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer 57
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 47
Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer 46
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance 44
Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells 40
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma 40
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients 33
Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer 31
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level 8
Totale 2.047
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.362
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 7 0 3 6 21 4 0 1 10 1 0 5
2021/2022155 0 21 6 4 35 6 19 6 7 6 11 34
2022/2023465 26 40 24 55 21 67 9 82 93 10 24 14
2023/2024302 30 41 19 9 12 73 7 15 5 19 46 26
2024/2025958 13 137 36 79 175 135 77 22 35 65 128 56
2025/202642 42 0 0 0 0 0 0 0 0 0 0 0
Totale 2.047